Cart
sales@molnova.com
ICA069673
CAS No. 582323-16-8
ICA069673( ICA-069673 | ICA 069673 | ICA069673 )
Catalog No. M17548 CAS No. 582323-16-8
ICA-069673 is an activator of KCNQ2/Q3 potassium channel (IC50: 0.69 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 60 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 231 | In Stock |
|
| 50MG | 411 | In Stock |
|
| 100MG | 611 | In Stock |
|
| 500MG | 1287 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameICA069673
-
NoteResearch use only, not for human use.
-
Brief DescriptionICA-069673 is an activator of KCNQ2/Q3 potassium channel (IC50: 0.69 μM).
-
DescriptionICA069673 is a heteromeric Kv7 channel activator. It is selective for Kv7.2/7.3 over Kv7.3/7.5 (EC50s = 0.69 and 14.3 μM, respectively). ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991.
-
In Vitro——
-
In Vivo——
-
SynonymsICA-069673 | ICA 069673 | ICA069673
-
PathwayAngiogenesis
-
TargetFAK
-
RecptorKCNQ2/Q3 potassium channel
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number582323-16-8
-
Formula Weight269.63
-
Molecular FormulaC11H6CLF2NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 34 mg/mL; 126.10 mM
-
SMILESc1cc(c(cc1C(=O)Nc1cnc(nc1)Cl)F)F
-
Chemical NameN-(2-chloro-5-pyrimidinyl)-3,4-difluoro-benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wickenden AD, et al. Mol Pharmacol. 2008 Mar;73(3):977-86. Epub 2007 Dec 18.
molnova catalog
related products
-
BI-4464
BI-4464 is a highly selective ATP competitive inhibitor of?PTK2/FAK with an?IC50?of 17 nM. A PTK2 ligand for PROTAC.
-
Defactinib
Defactinib (VS-6063, PF-04554878) is a potent, selective and orally active FAK inhibitor, selectively inhibits pFAK (Tyr397) in a dose-dependent manner in cancer cell lines.
-
FAK activator 1
ZINC40099027 is a specific adhesion plaque kinase (FAK) activator that promotes gastric mucosal repair in persistent aspirin-associated gastric injury through activation of adhesion plaque kinase, activates human adhesion plaque kinase by accelerating the enzyme activity of the structural domain of FAK kinase, activates cytosolic FAK, and promotes intestinal epithelial wound closure.
